ARTERRA BIOSCIENCE SPA (ARBS.MI) Fundamental Analysis & Valuation

BIT:ARBS • IT0005386369

Current stock price

2.72 EUR
-0.22 (-7.48%)
Last:

This ARBS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ARBS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year ARBS was profitable.
  • ARBS had a positive operating cash flow in the past year.
  • In the past 5 years ARBS has always been profitable.
  • Each year in the past 5 years ARBS had a positive operating cash flow.
ARBS.MI Yearly Net Income VS EBIT VS OCF VS FCFARBS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

1.2 Ratios

  • ARBS has a Return On Assets of 13.59%. This is amongst the best in the industry. ARBS outperforms 87.95% of its industry peers.
  • ARBS has a Return On Equity of 16.33%. This is amongst the best in the industry. ARBS outperforms 85.54% of its industry peers.
  • ARBS has a Return On Invested Capital of 13.11%. This is amongst the best in the industry. ARBS outperforms 87.95% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ARBS is in line with the industry average of 10.61%.
  • The 3 year average ROIC (9.13%) for ARBS is below the current ROIC(13.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.59%
ROE 16.33%
ROIC 13.11%
ROA(3y)9.93%
ROA(5y)10.02%
ROE(3y)11.74%
ROE(5y)12.1%
ROIC(3y)9.13%
ROIC(5y)9.66%
ARBS.MI Yearly ROA, ROE, ROICARBS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 42.38%, ARBS belongs to the top of the industry, outperforming 95.18% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ARBS has remained more or less at the same level.
  • The Operating Margin of ARBS (46.43%) is better than 93.98% of its industry peers.
  • In the last couple of years the Operating Margin of ARBS has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 63.60%, ARBS is in line with its industry, outperforming 55.42% of the companies in the same industry.
  • ARBS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 46.43%
PM (TTM) 42.38%
GM 63.6%
OM growth 3Y0.28%
OM growth 5Y-1.05%
PM growth 3Y3.33%
PM growth 5Y0.25%
GM growth 3Y-2.51%
GM growth 5Y-0.98%
ARBS.MI Yearly Profit, Operating, Gross MarginsARBS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ARBS.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARBS is creating some value.
  • ARBS has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ARBS has less shares outstanding
  • The debt/assets ratio for ARBS has been reduced compared to a year ago.
ARBS.MI Yearly Shares OutstandingARBS.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ARBS.MI Yearly Total Debt VS Total AssetsARBS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • ARBS has an Altman-Z score of 6.84. This indicates that ARBS is financially healthy and has little risk of bankruptcy at the moment.
  • ARBS's Altman-Z score of 6.84 is fine compared to the rest of the industry. ARBS outperforms 78.31% of its industry peers.
  • The Debt to FCF ratio of ARBS is 0.30, which is an excellent value as it means it would take ARBS, only 0.30 years of fcf income to pay off all of its debts.
  • ARBS's Debt to FCF ratio of 0.30 is amongst the best of the industry. ARBS outperforms 92.77% of its industry peers.
  • ARBS has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • ARBS's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. ARBS outperforms 75.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.3
Altman-Z 6.84
ROIC/WACC1.63
WACC8.05%
ARBS.MI Yearly LT Debt VS Equity VS FCFARBS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.3 Liquidity

  • ARBS has a Current Ratio of 7.40. This indicates that ARBS is financially healthy and has no problem in meeting its short term obligations.
  • ARBS has a Current ratio of 7.40. This is amongst the best in the industry. ARBS outperforms 90.36% of its industry peers.
  • A Quick Ratio of 6.31 indicates that ARBS has no problem at all paying its short term obligations.
  • ARBS's Quick ratio of 6.31 is amongst the best of the industry. ARBS outperforms 89.16% of its industry peers.
Industry RankSector Rank
Current Ratio 7.4
Quick Ratio 6.31
ARBS.MI Yearly Current Assets VS Current LiabilitesARBS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ARBS.MI Growth Analysis

3.1 Past

  • ARBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.48%, which is quite impressive.
  • The Earnings Per Share has been growing by 10.01% on average over the past years. This is quite good.
  • Looking at the last year, ARBS shows a quite strong growth in Revenue. The Revenue has grown by 13.44% in the last year.
  • Measured over the past years, ARBS shows a quite strong growth in Revenue. The Revenue has been growing by 9.02% on average per year.
EPS 1Y (TTM)37.48%
EPS 3Y8.02%
EPS 5Y10.01%
EPS Q2Q%109.79%
Revenue 1Y (TTM)13.44%
Revenue growth 3Y2.94%
Revenue growth 5Y9.02%
Sales Q2Q%14.28%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARBS.MI Yearly Revenue VS EstimatesARBS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

5

4. ARBS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.07 indicates a reasonable valuation of ARBS.
  • Compared to the rest of the industry, the Price/Earnings ratio of ARBS indicates a rather cheap valuation: ARBS is cheaper than 93.98% of the companies listed in the same industry.
  • ARBS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.54.
Industry RankSector Rank
PE 9.07
Fwd PE N/A
ARBS.MI Price Earnings VS Forward Price EarningsARBS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARBS is valued cheaply inside the industry as 93.98% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ARBS is valued cheaply inside the industry as 92.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.47
EV/EBITDA 6.22
ARBS.MI Per share dataARBS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The excellent profitability rating of ARBS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.91
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ARBS.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.64%, ARBS is a good candidate for dividend investing.
  • ARBS's Dividend Yield is rather good when compared to the industry average which is at 0.64. ARBS pays more dividend than 97.59% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ARBS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.64%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • ARBS pays out 44.46% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP44.46%
EPS Next 2YN/A
EPS Next 3YN/A
ARBS.MI Yearly Income VS Free CF VS DividendARBS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
ARBS.MI Dividend Payout.ARBS.MI Dividend Payout, showing the Payout Ratio.ARBS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARBS.MI Fundamentals: All Metrics, Ratios and Statistics

ARTERRA BIOSCIENCE SPA

BIT:ARBS (3/5/2026, 7:00:00 PM)

2.72

-0.22 (-7.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners46.87%
Ins Owner ChangeN/A
Market Cap18.12M
Revenue(TTM)4.49M
Net Income(TTM)1.90M
Analysts82.86
Price Target3.88 (42.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.64%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP44.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.07
Fwd PE N/A
P/S 4.03
P/FCF 17.47
P/OCF 9.53
P/B 1.55
P/tB 1.56
EV/EBITDA 6.22
EPS(TTM)0.3
EY11.03%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY5.72%
OCF(TTM)0.29
OCFY10.49%
SpS0.67
BVpS1.75
TBVpS1.75
PEG (NY)N/A
PEG (5Y)0.91
Graham Number3.44
Profitability
Industry RankSector Rank
ROA 13.59%
ROE 16.33%
ROCE 16.27%
ROIC 13.11%
ROICexc 17.92%
ROICexgc 17.98%
OM 46.43%
PM (TTM) 42.38%
GM 63.6%
FCFM 23.07%
ROA(3y)9.93%
ROA(5y)10.02%
ROE(3y)11.74%
ROE(5y)12.1%
ROIC(3y)9.13%
ROIC(5y)9.66%
ROICexc(3y)15.47%
ROICexc(5y)17.58%
ROICexgc(3y)15.82%
ROICexgc(5y)18.81%
ROCE(3y)11.33%
ROCE(5y)12.02%
ROICexgc growth 3Y-16.84%
ROICexgc growth 5Y-17%
ROICexc growth 3Y-14.48%
ROICexc growth 5Y-12.8%
OM growth 3Y0.28%
OM growth 5Y-1.05%
PM growth 3Y3.33%
PM growth 5Y0.25%
GM growth 3Y-2.51%
GM growth 5Y-0.98%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.3
Debt/EBITDA 0.11
Cap/Depr 269.44%
Cap/Sales 19.23%
Interest Coverage 250
Cash Conversion 78.96%
Profit Quality 54.44%
Current Ratio 7.4
Quick Ratio 6.31
Altman-Z 6.84
F-Score6
WACC8.05%
ROIC/WACC1.63
Cap/Depr(3y)76.68%
Cap/Depr(5y)90.12%
Cap/Sales(3y)7.07%
Cap/Sales(5y)10.14%
Profit Quality(3y)69.73%
Profit Quality(5y)57.78%
High Growth Momentum
Growth
EPS 1Y (TTM)37.48%
EPS 3Y8.02%
EPS 5Y10.01%
EPS Q2Q%109.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.44%
Revenue growth 3Y2.94%
Revenue growth 5Y9.02%
Sales Q2Q%14.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.77%
EBIT growth 3Y3.23%
EBIT growth 5Y7.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.65%
FCF growth 3Y-20.26%
FCF growth 5Y25.42%
OCF growth 1Y3.72%
OCF growth 3Y-8.67%
OCF growth 5Y-9.31%

ARTERRA BIOSCIENCE SPA / ARBS.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARTERRA BIOSCIENCE SPA?

ChartMill assigns a fundamental rating of 7 / 10 to ARBS.MI.


What is the valuation status of ARTERRA BIOSCIENCE SPA (ARBS.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to ARTERRA BIOSCIENCE SPA (ARBS.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ARTERRA BIOSCIENCE SPA?

ARTERRA BIOSCIENCE SPA (ARBS.MI) has a profitability rating of 8 / 10.


How sustainable is the dividend of ARTERRA BIOSCIENCE SPA (ARBS.MI) stock?

The dividend rating of ARTERRA BIOSCIENCE SPA (ARBS.MI) is 6 / 10 and the dividend payout ratio is 44.46%.